Formosa strikes exclusive deal with Arrotex to launch eye surgery drug in Australia & NZ
The innovative eyedrop targets inflammation and pain following ocular surgery
The innovative eyedrop targets inflammation and pain following ocular surgery
The Co-Dx PCR platform is designed to deliver gold-standard PCR accuracy in a compact, user-friendly device suitable for decentralized testing environments
The Ma’anshan site approval covers pastilles, oral liquids, and powders
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
The trial targets MCAS/MCAD, an under-recognized, debilitating condition with an unknown cause and no cure
The products will be manufactured in Goa India and marketed & distributed in Australian markets
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Subscribe To Our Newsletter & Stay Updated